A modified frailty index predicts complication, readmission, and 30-day mortality following the revision total hip arthroplasty.
MFI
Modified frailty index
Operative risk factors
Orthopaedics
Orthopedics
Revision
Risk assessment
Surgery
Total hip arthroplasty
Journal
Arthroplasty (London, England)
ISSN: 2524-7948
Titre abrégé: Arthroplasty
Pays: England
ID NLM: 101773073
Informations de publication
Date de publication:
04 Feb 2024
04 Feb 2024
Historique:
received:
08
06
2023
accepted:
02
01
2024
medline:
4
2
2024
pubmed:
4
2
2024
entrez:
3
2
2024
Statut:
epublish
Résumé
This study aimed to develop a modified frailty index (MFI) to predict the risks of revision total hip arthroplasty (THA). Data from the American College of Surgeons - National Surgical Quality Improvement Program were analyzed for patients who underwent revision THA from 2015 to 2020. An MFI was composed of the risk factors, including severe obesity (body mass index > 35), osteoporosis, non-independent function status prior to surgery, congestive heart failure within 30 days of surgery, hypoalbuminemia (serum albumin < 3.5), hypertension requiring medication, type 1 or type 2 diabetes, and a history of chronic obstructive pulmonary disease or pneumonia. The patients were assigned based on the MFI scores (MFI0, no risk factor; MFI1, 1-2 risk factors; MFI2, 3-4 risk factors; and MFI3, 5+ risk factors). Confidence intervals were set at 95% with a P value less than or equal to 0.05 considered statistically significant. A total of 17,868 patients (45% male, 55% female) were included and had an average age of 68.5 ± 11.5 years. Odds of any complication, when compared to MFI0, were 1.4 (95% CI [1.3, 1.6]) times greater for MFI1, 3.2 (95% CI [2.8, 3.6]) times greater for MFI2, and 10.8 (95% CI [5.8, 20.0]) times greater for MFI3 (P < 0.001). Odds of readmission, when compared to MFI0, were 1.4 (95% CI [1.3, 1.7]) times greater for MFI1, 2.5 (95% CI [2.1, 3.0]) times greater for MFI2, and 4.1 (95% CI [2.2, 7.8]) times greater for MFI3 (P < 0.001). Increasing MFI scores correlate with increased odds of complication and readmission in patients who have undergone revision THA. This MFI may be used to predict the risks after revision THA.
Identifiants
pubmed: 38310263
doi: 10.1186/s42836-024-00232-8
pii: 10.1186/s42836-024-00232-8
doi:
Types de publication
Journal Article
Langues
eng
Pagination
7Informations de copyright
© 2024. The Author(s).
Références
Daigle ME, Weinstein AM, Katz JN, Losina E. The cost-effectiveness of total joint arthroplasty: a systematic review of published literature. Best Pract Res Clin Rheumatol. 2012;26(5):649–58. https://doi.org/10.1016/j.berh.2012.07.013 .
doi: 10.1016/j.berh.2012.07.013
pubmed: 23218429
Hamilton DF, Lane JV, Gaston P, et al. What determines patient satisfaction with surgery? a prospective cohort study of 4709 patients following total joint replacement. BMJ Open. 2013;3(4):e002525. https://doi.org/10.1136/bmjopen-2012-002525 .
doi: 10.1136/bmjopen-2012-002525
pubmed: 23575998
pmcid: 3641464
Anderson AS, Loeser RF. Why is osteoarthritis an age-related disease? Best Pract Res Clin Rheumatol. 2010;24(1):15. https://doi.org/10.1016/j.berh.2009.08.006 .
doi: 10.1016/j.berh.2009.08.006
pmcid: 2818253
Evans JT, Evans JP, Walker RW, Blom AW, Whitehouse MR, Sayers A. How long does a hip replacement last? a systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up. Lancet. 2019;393(10172):647–54. https://doi.org/10.1016/S0140-6736(18)31665-9 .
doi: 10.1016/S0140-6736(18)31665-9
pubmed: 30782340
pmcid: 6376618
Bozic KJ, Kurtz SM, Lau E, Ong K, Vail TP, Berry DJ. The epidemiology of revision total hip arthroplasty in the United States. J Bone Joint Surg Am. 2009;91(1):128–33. https://doi.org/10.2106/JBJS.H.00155 .
doi: 10.2106/JBJS.H.00155
pubmed: 19122087
AAOS. American Academy of Orthopaedic Surgeons Annual Meeting 2018. Published online March 6, 2018. https://aaos-annualmeeting-presskit.org/2018/research-news/sloan_tjr/ . Accessed 31 Mar 2023.
Patel A, Pavlou G, Mújica-Mota RE, Toms AD. The epidemiology of revision total knee and hip arthroplasty in England and Wales: a comparative analysis with projections for the United States. a study using the National Joint Registry dataset. Bone Joint J. 2015;97-B(8):1076–81. https://doi.org/10.1302/0301-620X.97B8.35170 .
doi: 10.1302/0301-620X.97B8.35170
pubmed: 26224824
Changulani M, Kalairajah Y, Peel T, Field RE. The relationship between obesity and the age at which hip and knee replacement is undertaken. J Bone Joint Surg Br. 2008;90(3):360–3. https://doi.org/10.1302/0301-620X.90B3.19782 .
doi: 10.1302/0301-620X.90B3.19782
pubmed: 18310761
Flugsrud GB, Nordsletten L, Espehaug B, Havelin LI, Meyer HE. Risk factors for total hip replacement due to primary osteoarthritis: a cohort study in 50,034 persons. Arthritis Rheum. 2002;46(3):675–82. https://doi.org/10.1002/art.10115 .
doi: 10.1002/art.10115
pubmed: 11920403
Haynes A, Kersbergen I, Sutin A, Daly M, Robinson E. A systematic review of the relationship between weight status perceptions and weight loss attempts, strategies, behaviours and outcomes. Obes Rev. 2018;19(3):347–63. https://doi.org/10.1111/obr.12634 .
doi: 10.1111/obr.12634
pubmed: 29266851
Deere K, Whitehouse MR, Kunutsor SK, Sayers A, Mason J, Blom AW. How long do revised and multiply revised hip replacements last? a retrospective observational study of the National Joint Registry. The Lancet Rheumatol. 2022;4(7):e468–79. https://doi.org/10.1016/S2665-9913(22)00097-2 .
doi: 10.1016/S2665-9913(22)00097-2
pubmed: 36394063
Lan P, Chen X, Fang Z, Zhang J, Liu S, Liu Y. Effects of comorbidities on pain and function after total hip arthroplasty. Front Surg. 2022;9:829303. https://doi.org/10.3389/fsurg.2022.829303 .
doi: 10.3389/fsurg.2022.829303
pubmed: 35647007
pmcid: 9130629
Patel I, Nham F, Zalikha AK, El-Othmani MM. Epidemiology of total hip arthroplasty: demographics, comorbidities and outcomes. Arthroplasty. 2023;5(1):2. https://doi.org/10.1186/s42836-022-00156-1 .
doi: 10.1186/s42836-022-00156-1
pubmed: 36593482
pmcid: 9808997
Wilson JM, Schwartz AM, Farley KX, Bradbury TL, Guild GN. Combined malnutrition and frailty significantly increases complications and mortality in patients undergoing elective total hip arthroplasty. The J Arthroplasty. 2020;35(9):2488–94. https://doi.org/10.1016/j.arth.2020.04.028 .
doi: 10.1016/j.arth.2020.04.028
pubmed: 32444236
Edwards BJ, Langman CB, Bunta AD, Vicuna M, Favus M. Secondary contributors to bone loss in osteoporosis related hip fractures. Osteoporos Int. 2008;19(7):991–9. https://doi.org/10.1007/s00198-007-0525-7 .
doi: 10.1007/s00198-007-0525-7
pubmed: 18180974
Bellamy JL, Runner RP, Vu CCL, Schenker ML, Bradbury TL, Roberson JR. Modified frailty index is an effective risk assessment tool in primary total hip arthroplasty. J Arthroplasty. 2017;32(10):2963–8. https://doi.org/10.1016/j.arth.2017.04.056 .
doi: 10.1016/j.arth.2017.04.056
pubmed: 28559198
Weaver DJ, Malik AT, Jain N, Yu E, Kim J, Khan SN. The modified 5-item frailty index: a concise and useful tool for assessing the impact of frailty on postoperative morbidity following elective posterior lumbar fusions. World Neurosurg. 2019;124:e626–32. https://doi.org/10.1016/j.wneu.2018.12.168 .
doi: 10.1016/j.wneu.2018.12.168
pubmed: 30639495
Traven SA, Reeves RA, Sekar MG, Slone HS, Walton ZJ. New 5-factor modified frailty index predicts morbidity and mortality in primary hip and knee arthroplasty. The Journal of Arthroplasty. 2019;34(1):140–4. https://doi.org/10.1016/j.arth.2018.09.040 .
doi: 10.1016/j.arth.2018.09.040
pubmed: 30337252
Traven SA, Reeves RA, Althoff AD, Slone HS, Walton ZJ. New five-factor modified frailty index predicts morbidity and mortality in geriatric hip fractures. J Orthopaedic Trauma. 2019;33(7):319. https://doi.org/10.1097/BOT.0000000000001455 .
doi: 10.1097/BOT.0000000000001455
Shin JI, Keswani A, Lovy AJ, Moucha CS. Simplified frailty index as a predictor of adverse outcomes in total hip and knee arthroplasty. The J Arthroplasty. 2016;31(11):2389–94. https://doi.org/10.1016/j.arth.2016.04.020 .
doi: 10.1016/j.arth.2016.04.020
pubmed: 27240960
Zamanzadeh RS, Seilern Und Aspang J, Schwartz AM, Martin JR, Premkumar A, Wilson JM. Age-Adjusted Modified Frailty Index Predicts 30-Day Complications and Mortality in Aseptic Revision Total Hip and Knee Arthroplasty. J Arthroplasty. 2023;S0883-5403(23):00670–8. https://doi.org/10.1016/j.arth.2023.06.032 .
doi: 10.1016/j.arth.2023.06.032
Schwartz AM, Farley KX, Guild GN, Bradbury TL. Projections and epidemiology of revision hip and knee arthroplasty in the United States to 2030. J Arthroplasty. 2020;35(6, Supplement):S79–85. https://doi.org/10.1016/j.arth.2020.02.030 .
doi: 10.1016/j.arth.2020.02.030
pubmed: 32151524
pmcid: 7239745
Lübbeke A, Moons KGM, Garavaglia G, Hoffmeyer P. Outcomes of obese and nonobese patients undergoing revision total hip arthroplasty. Arthritis Care Res. 2008;59(5):738–45. https://doi.org/10.1002/art.23562 .
doi: 10.1002/art.23562
Roth A, Khlopas A, George J, et al. The effect of body mass index on 30-day complications after revision total hip and knee arthroplasty. J Arthroplasty. 2019;34(7, Supplement):S242–8. https://doi.org/10.1016/j.arth.2019.02.005 .
doi: 10.1016/j.arth.2019.02.005
pubmed: 30846315
Koenig K, Huddleston JI, Huddleston H, Maloney WJ, Goodman SB. Advanced age and comorbidity increase the risk for adverse events after revision total hip arthroplasty. The J Arthroplasty. 2012;27(7):1402-1407.e1. https://doi.org/10.1016/j.arth.2011.11.013 .
doi: 10.1016/j.arth.2011.11.013
pubmed: 22245123
Badarudeen S, Shu AC, Ong KL, Baykal D, Lau E, Malkani AL. Complications after revision total hip arthroplasty in the medicare population. The J Arthroplasty. 2017;32(6):1954–8. https://doi.org/10.1016/j.arth.2017.01.037 .
doi: 10.1016/j.arth.2017.01.037
pubmed: 28236550
Johnson RL, Abdel MP, Frank RD, Chamberlain AM, Habermann EB, Mantilla CB. Impact of frailty on outcomes after primary and revision total hip arthroplasty. The J Arthroplasty. 2019;34(1):56-64.e5. https://doi.org/10.1016/j.arth.2018.09.078 .
doi: 10.1016/j.arth.2018.09.078
pubmed: 30340916
Meyer M, Schwarz T, Renkawitz T, Maderbacher G, Grifka J, Weber M. Hospital frailty risk score predicts adverse events in revision total hip and knee arthroplasty. Int Orthopaedics (SICOT). 2021;45(11):2765–72. https://doi.org/10.1007/s00264-021-05038-w .
doi: 10.1007/s00264-021-05038-w
Liu SS, González Della Valle A, Besculides MC, Gaber LK, Memtsoudis SG. Trends in mortality, complications, and demographics for primary hip arthroplasty in the United States. Int Orthop. 2009;33(3):643–51. https://doi.org/10.1007/s00264-008-0549-4 .
doi: 10.1007/s00264-008-0549-4
pubmed: 18461326